Partners With Apothecary For Full CVS Launch
Innovation Institute, founded five years ago as an incubator to commercialize internal medical innovation by doctors, nurses and other hospital care providers in its six health system-owners network, has done exactly that.
Hires Planned For Home-Care Frontier
Revenue from Irvine-based Masimo Corp.’s noninvasive patient monitoring technologies grew last year by 15% to $798.1 million, and Chief Executive Joe Kiani said the company plans to grow its new telehealth initiative.
FINANCE: Netlist was worst performer in TTM
Now the envelopes for the five best- and five worst-performing stocks during the year ended March 29:
Irvine-based Inari Medical Inc. received $27 million in a series C round to support commercialization.
Irvine-based Axonics Modulation Technologies received a $40.1 million financing comprised of $20.1 million in equity and a $20 million credit facility.
Five Point Holdings LLC and City of Hope said today they plan to build a $200 million cancer center at the Great Park Neighborhoods in Irvine.
Fujifilm Holdings plans to buy a pair of cell culture media businesses owned by Japanese oil and metals conglomerate JXTG Holdings for about $800 million.
Justice Department lawyers said this week they plan to try medical-device executive Jim Mazzo for a third time for violating insider trading rules after two prior efforts ended in hung juries.
Providence St. Joseph named Victor Jordan chief operating officer for Providence St. Joseph Health Southern California, effective March 26.
Hoag Memorial Hospital Presbyterian in Newport Beach has assumed the title sponsorship of Orange County’s only PGA Tour event, renaming it the Hoag Classic.
Seattle-based SightLife Surgical Inc. will buy the Kamra inlay from AcuFocus Inc. in Irvine on undisclosed terms in a deal expected to close this month.
Long Beach Medical Center filed a 120-day lease termination notice on behalf of Community Medical Center Long Beach.
Biologics manufacturer Avid Bioservices Inc. announced Chief Financial Officer Paul Lytle resigned, effective May 24.
Nemus Bioscience Inc. (OTCQB: NMUS) received a $1.75 million private placement from majority shareholder Emerald Health Sciences Inc. and other investors.